|
gptkbp:instanceOf
|
gptkb:chemical_compound
fatty acid amide hydrolase inhibitor
|
|
gptkbp:CASNumber
|
546141-08-6
|
|
gptkbp:category
|
carbamate
biphenyl compound
|
|
gptkbp:discoveredBy
|
gptkb:Daniele_Piomelli
|
|
gptkbp:drugClass
|
gptkb:enzyme
|
|
gptkbp:effect
|
increases levels of anandamide
increases levels of other endocannabinoids
|
|
gptkbp:firstDescribed
|
2003
|
|
gptkbp:hasMolecularFormula
|
C20H22N2O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
URB597
|
|
gptkbp:IUPACName
|
cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester
|
|
gptkbp:legalStatus
|
not approved for medical use
|
|
gptkbp:mechanismOfAction
|
inhibits fatty acid amide hydrolase (FAAH)
|
|
gptkbp:molecularWeight
|
322.4 g/mol
|
|
gptkbp:PubChem_CID
|
9866582
CHEBI:131722
CHEMBL23437
|
|
gptkbp:routeOfAdministration
|
oral
intraperitoneal
|
|
gptkbp:synonym
|
KDS-4103
cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester
|
|
gptkbp:target
|
gptkb:fatty_acid_amide_hydrolase
|
|
gptkbp:UNII
|
6QK7B6W8RL
|
|
gptkbp:usedInResearchOn
|
gptkb:depression
pain
anxiety
neuroprotection
|
|
gptkbp:bfsParent
|
gptkb:fatty_acid_amide_hydrolase
gptkb:FAAH_inhibitors
|
|
gptkbp:bfsLayer
|
7
|